구조적 심장 디바이스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Structural Heart Devices Market size is expected to reach USD 42.23 Billion in 2034 from USD 22.82 Billion (2025) growing at a CAGR of 7.08% during 2026-2034.

The global structural heart devices market has experienced strong growth due to rising cases of heart valve disorders. These devices are used to treat structural defects without open-heart surgery. Increasing preference for minimally invasive procedures has supported market expansion.

Major drivers include aging populations and advancements in medical technology. Improved imaging systems and device designs have enhanced treatment outcomes. Growing awareness about early diagnosis and expanding cardiac care facilities also contribute to growth.

In the future, the market is expected to grow with the development of innovative transcatheter devices. Expanding healthcare access in emerging markets will create opportunities. However, high device costs and regulatory requirements may limit adoption. Overall, rising focus on heart health will drive long-term demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Biological/Tissue Valves
• Mechanical Heart Valves
• Annuloplasty Rings
• Occluders
• Accessories

By Procedure

• Replacement Procedures
• Repair Procedures

By Indication

• Valve Stenosis
• Valve Regurgitation
• Cardiomyopathy
• Congenital Heart Defects
• Others

COMPANIES PROFILED

• Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova plc, Lepu Medical, Micro Interventional Devices Inc, LifeTech Scientific Corporation, Cryolife Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Biological/Tissue Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Mechanical Heart Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Annuloplasty Rings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Occluders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Replacement Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Repair Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Valve Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Valve Regurgitation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cardiomyopathy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Congenital Heart Defects Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Procedure
  • 7.2.3 By Indication
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Procedure
  • 7.3.3 By Indication
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Procedure
  • 7.4.3 By Indication
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Procedure
  • 7.5.3 By Indication
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Procedure
  • 7.6.3 By Indication
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL STRUCTURAL HEART DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Abbott
  • 9.2.3 Boston Scientific Corporation
  • 9.2.4 Edwards Lifesciences Corporation
  • 9.2.5 LivaNova Plc
  • 9.2.6 Lepu Medical
  • 9.2.7 Micro Interventional Devices Inc
  • 9.2.8 LifeTech Scientific Corporation
  • 9.2.9 Cryolife Inc